Back

BIO-LIBRA study

14 April 2026 (11:00 - 11:10)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Science: ablation and drug therapy Cardioversion and Defibrillation EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Valentina Kutyifa

University of Rochester, Rochester (United States of America)

11 More presentations in this session

Presentation thumbnail
FLECA-ED trial. Flecainide for acute atrial fibrillation cardioversion in ischemic heart disease
Doctor P. Tsioufis (Athens, GR)
Slides Video
Presentation thumbnail
Discussant review - FLECA-ED
Professor M. Rienstra (Groningen, NL)
Slides Video
Presentation thumbnail
Discussion - FLECA-ED
Video
Presentation thumbnail
Discussant review - BIO-LIBRA
Professor J. Merino (Madrid, ES)
Slides Video
Presentation thumbnail
Discussion - BIO-LIBRA
Video

Access the full session

Session thumbnail
Late-Breaking Science: ablation and drug therapy
Video

The Event

Event poster

EHRA 2026

14 April 2026 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Effect of SGLT2 inhibitors in sustained ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators for primary prevention
thumbnail
Congress Presentation
Discussant review - BIO-LIBRA
thumbnail
Congress Presentation
Impact of SLGT2 inhibitors treatment initiation on the reduction of atrial and ventricular arrhythmias in patients with implanted cardiac device

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources